ASX - By Stock
|
HMD |
Re:
Ann: Binding Strategic Partnership Agreement signed US FemBridge
|
|
Level2
|
25 |
5.1K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
25
|
5.1K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore secures Singapore and Vietnam market approvals
|
|
Level2
|
49 |
19K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
49
|
19K
|
0
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Prospectus for Renounceable Rights Issue
|
|
Level2
|
45 |
16K |
0 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
45
|
16K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Binding Strategic Partnership Agreement signed US FemBridge
|
|
Level2
|
25 |
5.1K |
0 |
15/03/24 |
15/03/24 |
ASX - By Stock
|
25
|
5.1K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
40 |
8.7K |
1 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
40
|
8.7K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Suspension from Official Quotation
|
|
Level2
|
6 |
1.5K |
4 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
6
|
1.5K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Suspension from Official Quotation
|
|
Level2
|
6 |
1.5K |
2 |
26/02/24 |
26/02/24 |
ASX - By Stock
|
6
|
1.5K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Despatch of Rights Issue Offer Materials
|
|
Level2
|
20 |
2.5K |
0 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
20
|
2.5K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
19 |
3.8K |
0 |
13/12/23 |
13/12/23 |
ASX - By Stock
|
19
|
3.8K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Clinical Trial launched at Gold Coast Hospital
|
|
Level2
|
23 |
3.3K |
4 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
23
|
3.3K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Notification regarding unquoted securities - HMD
|
|
Level2
|
52 |
8.0K |
0 |
20/10/23 |
20/10/23 |
ASX - By Stock
|
52
|
8.0K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Level2
|
50 |
10K |
7 |
03/10/23 |
03/10/23 |
ASX - By Stock
|
50
|
10K
|
7
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Level2
|
50 |
10K |
3 |
25/09/23 |
25/09/23 |
ASX - By Stock
|
50
|
10K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Level2
|
50 |
10K |
2 |
19/09/23 |
19/09/23 |
ASX - By Stock
|
50
|
10K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Appendix 4D and Half Year Report
|
|
Level2
|
160 |
25K |
6 |
18/09/23 |
18/09/23 |
ASX - By Stock
|
160
|
25K
|
6
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Appendix 4D and Half Year Report
|
|
Level2
|
160 |
25K |
2 |
06/09/23 |
06/09/23 |
ASX - By Stock
|
160
|
25K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Appendix 4D and Half Year Report
|
|
Level2
|
160 |
25K |
4 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
160
|
25K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: New Appointments to Strengthen USA Commercialisation
|
|
Level2
|
51 |
9.2K |
2 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
51
|
9.2K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: New Appointments to Strengthen USA Commercialisation
|
|
Level2
|
51 |
9.2K |
0 |
02/08/23 |
02/08/23 |
ASX - By Stock
|
51
|
9.2K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
11K |
0 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
58
|
11K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
11K |
1 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
58
|
11K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
11K |
1 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
11K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
11K |
0 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
11K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
11K |
2 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
11K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
11K |
7 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
11K
|
7
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
11K |
1 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
11K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
58 |
11K |
1 |
10/07/23 |
10/07/23 |
ASX - By Stock
|
58
|
11K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Dr Ron Weinberger appointed Executive Chairman
|
|
Level2
|
44 |
8.8K |
4 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
44
|
8.8K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Dr Ron Weinberger appointed Executive Chairman
|
|
Level2
|
44 |
8.8K |
2 |
05/07/23 |
05/07/23 |
ASX - By Stock
|
44
|
8.8K
|
2
|
|
Charts
|
HMD |
Re:
HMD Chart
|
|
Level2
|
677 |
168K |
1 |
04/07/23 |
04/07/23 |
Charts
|
677
|
168K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Dr Ron Weinberger appointed Executive Chairman
|
|
Level2
|
44 |
8.8K |
4 |
03/07/23 |
03/07/23 |
ASX - By Stock
|
44
|
8.8K
|
4
|
|
ASX - By Stock
|
HMD |
Re:
Ann: E-Lovu signs first 3 year commercial agreement
|
|
Level2
|
57 |
11K |
1 |
26/06/23 |
26/06/23 |
ASX - By Stock
|
57
|
11K
|
1
|
|
Charts
|
HMD |
Re:
HMD Chart
|
|
Level2
|
677 |
168K |
3 |
20/06/23 |
20/06/23 |
Charts
|
677
|
168K
|
3
|
|
Charts
|
HMD |
Re:
HMD Chart
|
|
Level2
|
677 |
168K |
3 |
14/06/23 |
14/06/23 |
Charts
|
677
|
168K
|
3
|
|
Charts
|
HMD |
Re:
HMD Chart
|
|
Level2
|
677 |
168K |
2 |
14/06/23 |
14/06/23 |
Charts
|
677
|
168K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Further information - Strategic Partnership Rewards Platform
|
|
Level2
|
50 |
7.3K |
3 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
50
|
7.3K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Further information - Strategic Partnership Rewards Platform
|
|
Level2
|
50 |
7.3K |
1 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
50
|
7.3K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Trading Halt
|
|
Level2
|
29 |
5.1K |
2 |
06/06/23 |
06/06/23 |
ASX - By Stock
|
29
|
5.1K
|
2
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Strategic Partnership signed - US employee rewards platform
|
|
Level2
|
41 |
6.9K |
0 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
41
|
6.9K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Strategic Partnership signed - US employee rewards platform
|
|
Level2
|
41 |
6.9K |
1 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
41
|
6.9K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Strategic Partnership signed - US employee rewards platform
|
|
Level2
|
41 |
6.9K |
0 |
05/06/23 |
05/06/23 |
ASX - By Stock
|
41
|
6.9K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Contract signed with private Obstetrics & Gynaecology Group
|
|
Level2
|
36 |
8.1K |
3 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
36
|
8.1K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Contract signed with private Obstetrics & Gynaecology Group
|
|
Level2
|
36 |
8.1K |
10 |
11/05/23 |
11/05/23 |
ASX - By Stock
|
36
|
8.1K
|
10
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Quarterly Activities & Cashflow Report
|
|
Level2
|
55 |
11K |
5 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
55
|
11K
|
5
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Board & Management changes
|
|
Level2
|
17 |
3.7K |
5 |
21/04/23 |
21/04/23 |
ASX - By Stock
|
17
|
3.7K
|
5
|
|
ASX - By Stock
|
HMD |
Re:
Quarterly
|
|
Level2
|
35 |
8.0K |
3 |
04/04/23 |
04/04/23 |
ASX - By Stock
|
35
|
8.0K
|
3
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Gold Coast Hospital to begin trial of the HeraCARE Platform
|
|
Level2
|
56 |
12K |
1 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
56
|
12K
|
1
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Change of Director's Interest Notice
|
|
Level2
|
7 |
1.8K |
0 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
7
|
1.8K
|
0
|
|
ASX - By Stock
|
PL3 |
Re:
IPO - Patagonia Lithium Ltd - 19 December 2022 #
|
|
Level2
|
109 |
124K |
0 |
27/03/23 |
27/03/23 |
ASX - By Stock
|
109
|
124K
|
0
|
|
ASX - By Stock
|
HMD |
Re:
Ann: Gold Coast Hospital to begin trial of the HeraCARE Platform
|
|
Level2
|
56 |
12K |
3 |
22/03/23 |
22/03/23 |
ASX - By Stock
|
56
|
12K
|
3
|
|